Myocardial Ischemia Past Paper PDF
Document Details
Uploaded by IncredibleTensor
University of Utah
Tags
Summary
These notes cover myocardial ischemia, including its causes, pathophysiology, and clinical consequences. The document delves into various types of ischemic pain and myocardial infarction. The information is suitable for advanced pathophysiology students studying cardiovascular diseases.
Full Transcript
Myocardial Ischemia *Partial blockage of one or more branches of the left or right coronary artery* [Causes] **Coronary atherosclerosis (coronary artery disease)** Repetitious endothelial injury with the resulting inflammatory response in the blood vessel wall results in a buildup of fibrous cap...
Myocardial Ischemia *Partial blockage of one or more branches of the left or right coronary artery* [Causes] **Coronary atherosclerosis (coronary artery disease)** Repetitious endothelial injury with the resulting inflammatory response in the blood vessel wall results in a buildup of fibrous caps and plaque, which restricts blood flow to coronary arteries. **Other causes/contributing factors include**: Vasospasms of coronary artery (called Prinzmetal or variant angina) Decreased oxygen supply to myocardium (e.g., hypoxemia, anemia) Increased myocardial demand (increased heart rate or CO) [Pathophysiology ] Coronary atherosclerosis results in myocardial ischemia Oxygen demand of ventricle exceeds oxygen supply in the coronary arteries [Clinical Consequences] **Decreased ventricular contractility** **Conduction disturbances** **Ischemic Pain** Stable angina pectoris *Intermittent chest pain occurring with the same pattern of onset, duration and intensity* Unstable angina pectoris *Chest pain lasting 15 to 20 minutes not relieved by rest, position change, or nitroglycerin* Myocardial Infarction *Severe reduction of coronary artery blood flow leading to myocardial cell death* [Causes] Coronary atherosclerosis (coronary artery disease) *Other less common causes include*: *Precipitating conditions include factors that increase metabolic demand*: *Precipitating conditions include factors that reduce the oxygen content of the blood*: [Types ] *There are several schemes used to classify types of MI for the purpose of directing treatment. (Don't memorize)* +-----------------------------------+-----------------------------------+ | *Classification* | *Description of Categories* | +===================================+===================================+ | Morphologic | **Transmural**: necrosis extends | | | throughout the entire wall of the | | | myocardium | | | | | | **Non-transmural**: necrosis is | | | limited to the endocardium or | | | subendocardium (most frequent), | | | or a segment of the myocardium. | +-----------------------------------+-----------------------------------+ | STEMI vs. NSTEMI | **STEMI**: MI in the presence of | | | ST segment elevation on the ECG | | | | | | **NSTEMI**: no ST segment | | | elevation | +-----------------------------------+-----------------------------------+ | Fourth Universal Definition of | **Myocardial Injury:** Elevated | | Myocardial Infarction (2018) | troponin with at least one value | | | \> 99 %ile | | | | | | **Type 1**: MI related to acute | | | athero-thrombosis of artery | | | feeding the infarcted myocardium | | | | | | **Type 2**: Supply-demand | | | mismatch unrelated to acute | | | athero-thrombosis | | | | | | **Type 3**: Cardiac death in | | | patients with symptoms suggestive | | | of myocardial ischemia and | | | presumed new ischemic EKG changes | | | before troponin levels available | | | or abnormal | | | | | | **Type 4a**: MI associated with | | | percutaneous coronary | | | intervention | | | | | | **Type 4b:** MI related to stent | | | thrombosis | | | | | | **Type 4c:** MI related to | | | restenosis | | | | | | **Type 5**: MI related to CABG | +-----------------------------------+-----------------------------------+ [Pathophysiology ] Infarction of an atherosclerotic coronary artery generally occurs due to the following circumstances: **Hypoxic injury** Within 10 seconds of infarction, see hypoxic injury to myocardial cells. Consequences of anaerobic metabolism include decreased ATP production & lactic acid formation. Anaerobic metabolism is insufficient - after 20 minutes of complete occlusion, irreversible injury and cell death begins in the affected areas. **Inflammation** Neutrophils release a myriad of inflammatory mediators, some of which can cause myocardial cell injury (e.g., NO, IL-1, TNF, etc) Neutrophils also release reactive oxygen species (ROS) and lysosomal enzymes during phagocytosis, which also contributes to myocardial cell injury **Reperfusion injury** If the hypoxic myocardial tissue is reperfused (thrombolytic therapy or percutaneous coronary intervention), further cardiac injury occurs due to *oxidative stress*. Introducing oxygen to tissue that has been hypoxic causes the formation of reactive oxygen species (i.e., free radicals) *Note:* Microvascular (capillary) obstruction due to microthrombi, small plaque fragments, lipids, and or endothelial injury can reduce effectiveness of reperfusion. **\ ** **Repair and resolution** Coagulative necrosis develops at site of infarct. Inflammation leads to scar tissue deposition at the site of infarct (and other changes in the surrounding tissue described on the next page). [Clinical Consequences] *Functional impairment depends on location and severity of infarct* Decreased ventricular (and atrial) contractility Conduction disturbances Ischemic pain [\ Laboratory Evaluation -- Cardiac Biomarkers] **Troponin I & T** *Cardiac troponin I and T are proteins unique to myocardial muscle cells, and are only released into circulation after myocardial cell injury.* Elevated (positive) troponin levels (cardiac TnI and TnT via immunoassay) are considered diagnostic of an acute MI (best sensitivity and specificity of the cardiac biomarkers) Levels rise within 2-3 hours after onset of chest pain, peak within 12 to 48 hours, and remain elevated for 4-10 days. *Note: Elevated troponin levels in the absence of ECG changes (e.g., without ST elevation) is a risk factor for dying from a future cardiac event* **CK-MB (Creatine Kinase -- muscle and brain type)** *Enzyme found primarily in myocardial muscle cells that is released after cell injury* Sensitivity of test is improved by using the CK-MB/total CK index (ratio \> 5 indicates cardiac source of CK-MB) Rises 4-6 hours after the MI, peaking in 24 hours, and disappearing in 2-3 days. **Myoglobin** *An intracellular protein similar to hemoglobin that is released after myocardial cell injury* Rises in myoglobin are very sensitive, but not very specific to acute MI **\ ** **C-Reactive Protein (CRP)** *Plasma protein (acute phase reactant) that is released by the liver during inflammation* Elevations greater than 1 mg/L are associated with increased risk of cardiovascular disease. Any level \> 3 mg/L is associated with a high risk for heart disease Elevated CRP is a reliable predictor of degree of heart failure and mortality following an AMI, but lacks specificity because it is a general marker for inflammation. **Lactate dehydrogenase (LDH)** *LDH is an intracellular enzyme (present in the cytoplasm of all cells) that catalyzes the process of converting pyruvate to lactate. It is also found in the plasma.* **FYI - Other Lab Findings** Elevated glucose CBC -- Elevated WBC count Chemistry -- Elevated potassium Lipid profile -- see 'atherosclerosis'